Would anti-choking devices be correctly and quickly managed by health science students? A manikin crossover trial.

Airway clearance DeCHOKER® FBAO LifeVac® Nursing and medical students Simulation

Journal

BMC medical education
ISSN: 1472-6920
Titre abrégé: BMC Med Educ
Pays: England
ID NLM: 101088679

Informations de publication

Date de publication:
23 May 2023
Historique:
received: 01 09 2022
accepted: 10 05 2023
medline: 25 5 2023
pubmed: 24 5 2023
entrez: 23 5 2023
Statut: epublish

Résumé

The brand-new anti-choking devices (LifeVac® and DeCHOKER®) have been recently developed to treat Foreign Body Airway Obstruction (FBAO). However, the scientific evidence around these devices that are available to the public is limited. Therefore, this study aimed to assess the ability to use the LifeVac® and DeCHOKER® devices in an adult FBAO simulated scenario, by untrained health science students. Forty-three health science students were asked to solve an FBAO event in three simulated scenarios: 1) using the LifeVac®, 2) using the DeCHOKER®, and 3) following the recommendations of the current FBAO protocol. A simulation-based assessment was used to analyze the correct compliance rate in the three scenarios based on the correct execution of the required steps, and the time it took to complete each one. Participants achieved correct compliance rates between 80-100%, similar in both devices (p = 0.192). Overall test times were significantly shorter with LifeVac® than DeCHOKER® device (36.6 sec. [31.9-44.4] vs. 50.4 s [36.7-66.9], p < 0.001). Regarding the recommended protocol, a 50% correct compliance rate was obtained in those with prior training vs. 31.3% without training, (p = 0.002). Untrained health science students are able to quickly and adequately use the brand-new anti-choking devices but have more difficulties in applying the current recommended FBAO protocol.

Sections du résumé

BACKGROUND BACKGROUND
The brand-new anti-choking devices (LifeVac® and DeCHOKER®) have been recently developed to treat Foreign Body Airway Obstruction (FBAO). However, the scientific evidence around these devices that are available to the public is limited. Therefore, this study aimed to assess the ability to use the LifeVac® and DeCHOKER® devices in an adult FBAO simulated scenario, by untrained health science students.
METHODS METHODS
Forty-three health science students were asked to solve an FBAO event in three simulated scenarios: 1) using the LifeVac®, 2) using the DeCHOKER®, and 3) following the recommendations of the current FBAO protocol. A simulation-based assessment was used to analyze the correct compliance rate in the three scenarios based on the correct execution of the required steps, and the time it took to complete each one.
RESULTS RESULTS
Participants achieved correct compliance rates between 80-100%, similar in both devices (p = 0.192). Overall test times were significantly shorter with LifeVac® than DeCHOKER® device (36.6 sec. [31.9-44.4] vs. 50.4 s [36.7-66.9], p < 0.001). Regarding the recommended protocol, a 50% correct compliance rate was obtained in those with prior training vs. 31.3% without training, (p = 0.002).
CONCLUSIONS CONCLUSIONS
Untrained health science students are able to quickly and adequately use the brand-new anti-choking devices but have more difficulties in applying the current recommended FBAO protocol.

Identifiants

pubmed: 37221498
doi: 10.1186/s12909-023-04345-7
pii: 10.1186/s12909-023-04345-7
pmc: PMC10204033
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

365

Informations de copyright

© 2023. The Author(s).

Références

Am J Emerg Med. 2016 Aug;34(8):1673-4
pubmed: 27260557
Resuscitation. 2020 Nov;156:174-181
pubmed: 32949674
J Community Health. 2019 Oct;44(5):974-981
pubmed: 30993473
BMJ Open. 2020 Jul 20;10(7):e039689
pubmed: 32690753
Rev Esp Cardiol (Engl Ed). 2020 Jan;73(1):53-68
pubmed: 30808611
BMC Med Educ. 2021 Nov 19;21(1):586
pubmed: 34798890
Simul Healthc. 2011 Aug;6 Suppl:S58-62
pubmed: 21817863
Resusc Plus. 2021 Apr 10;6:100117
pubmed: 34223376
Resuscitation. 2020 Aug;153:219-226
pubmed: 32114068
Resuscitation. 2011 Jun;82(6):657-64
pubmed: 21458137
Front Public Health. 2020 Dec 09;8:541885
pubmed: 33425826
Front Med (Lausanne). 2022 Feb 02;8:742734
pubmed: 35186960
Resuscitation. 2022 Aug;177:5-6
pubmed: 35697175
Resuscitation. 2020 Dec;157:133-134
pubmed: 33122014
Acad Emerg Med. 2018 Feb;25(2):168-176
pubmed: 28963862
Resuscitation. 2021 Apr;161:98-114
pubmed: 33773835
Int J Pediatr Otorhinolaryngol. 2019 Mar;118:31-35
pubmed: 30578993
Resuscitation. 2020 Aug;153:258-259
pubmed: 32473175
Resuscitation. 2019 Feb;135:153-161
pubmed: 30391370
Resusc Plus. 2021 Jan 08;5:100067
pubmed: 34223337

Auteurs

Borja Cardalda-Serantes (B)

Anesthesiology and Intensive Care Medicine Department, University Clinic Hospital of Santiago de Compostela (CHUS), Galician Public Health System (SERGAS), Santiago de Compostela, Spain.

Aida Carballo-Fazanes (A)

CLINURSID Research Group, University of Santiago de Compostela, Santiago de Compostela, Spain. aida.carballo.fazanes@usc.es.
Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin (RICORS), Instituto de Salud Carlos III, RD21/0012/0025, Madrid, Spain. aida.carballo.fazanes@usc.es.
Simulation, Life Support, and Intensive Care Research Unit (SICRUS), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. aida.carballo.fazanes@usc.es.

Emilio Rodríguez-Ruiz (E)

CLINURSID Research Group, University of Santiago de Compostela, Santiago de Compostela, Spain.
Simulation, Life Support, and Intensive Care Research Unit (SICRUS), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Intensive Care Medicine Department, University Clinic Hospital of Santiago de Compostela (CHUS), Galician Public Health System (SERGAS), Santiago de Compostela, Spain.

Cristian Abelairas-Gómez (C)

CLINURSID Research Group, University of Santiago de Compostela, Santiago de Compostela, Spain.
Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin (RICORS), Instituto de Salud Carlos III, RD21/0012/0025, Madrid, Spain.
Simulation, Life Support, and Intensive Care Research Unit (SICRUS), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Faculty of Education Sciences, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Antonio Rodríguez-Núñez (A)

CLINURSID Research Group, University of Santiago de Compostela, Santiago de Compostela, Spain.
Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin (RICORS), Instituto de Salud Carlos III, RD21/0012/0025, Madrid, Spain.
Simulation, Life Support, and Intensive Care Research Unit (SICRUS), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Intensive Care Medicine Department, University Clinic Hospital of Santiago de Compostela (CHUS), Galician Public Health System (SERGAS), Santiago de Compostela, Spain.
Pediatric Critical, Intermediate and Palliative Care Section, Pediatric Department. Hospital, Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH